80 related articles for article (PubMed ID: 2230284)
1. In vivo toxicity of 3'-azido-3'-deoxythymidine (AZT) on CBA/Ca mice.
Cronkite EP; Bullis J
Int J Cell Cloning; 1990 Sep; 8(5):332-45. PubMed ID: 2230284
[TBL] [Abstract][Full Text] [Related]
2. Acute toxic effects of 3'-azido-3'-deoxythymidine (AZT) on normal and regenerating murine hematopoiesis.
Scheding S; Media JE; Nakeff A
Exp Hematol; 1994 Jan; 22(1):60-5. PubMed ID: 8282060
[TBL] [Abstract][Full Text] [Related]
3. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
[TBL] [Abstract][Full Text] [Related]
4. Long-term bone marrow stromal and hemopoietic toxicity to AZT: protective role of heme and IL-1.
Abraham NG; Chertkov JL; Staudinger R; Jiang S; Lutton JD; Argani I; Levere RD; Kappas A
Exp Hematol; 1993 Feb; 21(2):263-8. PubMed ID: 7678812
[TBL] [Abstract][Full Text] [Related]
5. 3'-Azido-3'-deoxythymidine ameliorates the thrombocytopenia observed in a murine model of AIDS.
Chow FP; Sutton PA; Hamburger AW
Exp Hematol; 1990 Oct; 18(9):1038-41. PubMed ID: 2168839
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of hematopoietic progenitor cell proliferation by ethanol in human immunodeficiency virus type 1 tat-expressing transgenic mice.
Prakash O; Rodriguez VE; Tang ZY; Zhou P; Coleman R; Dhillon G; Shellito JE; Nelson S
Alcohol Clin Exp Res; 2001 Mar; 25(3):450-6. PubMed ID: 11290858
[TBL] [Abstract][Full Text] [Related]
7. Time-dependent changes induced by azidothymidine in erythroid progenitor colonies in immunodeficient mice.
Chow FP; Hamburger AW
Exp Hematol; 1992 Feb; 20(2):245-50. PubMed ID: 1544395
[TBL] [Abstract][Full Text] [Related]
8. The tetrapeptide AcSerAspLysPro (Seraspenide), a hematopoietic inhibitor, may reduce the in vitro toxicity of 3'-azido-3'-deoxythymidine to human hematopoietic progenitors.
Grillon C; Bonnet D; Mary JY; Lenfant M; Najman A; Guigon M
Stem Cells; 1993 Sep; 11(5):455-64. PubMed ID: 8241956
[TBL] [Abstract][Full Text] [Related]
9. Long-term oral cadmium produces bone marrow hypoplasia in mice.
Hays EF; Margaretten N
Exp Hematol; 1985 Mar; 13(3):229-34. PubMed ID: 3979472
[TBL] [Abstract][Full Text] [Related]
10. Zidovudine toxicity to murine bone marrow may be affected by the exact frequency of drug administration.
Agur Z; Arnon R; Sandak B; Schechter B
Exp Hematol; 1991 Jun; 19(5):364-8. PubMed ID: 2026186
[TBL] [Abstract][Full Text] [Related]
11. Catabolism of 3'-azido-3'-deoxythymidine in hepatocytes and liver microsomes, with evidence of formation of 3'-amino-3'-deoxythymidine, a highly toxic catabolite for human bone marrow cells.
Cretton EM; Xie MY; Bevan RJ; Goudgaon NM; Schinazi RF; Sommadossi JP
Mol Pharmacol; 1991 Feb; 39(2):258-66. PubMed ID: 1996084
[TBL] [Abstract][Full Text] [Related]
12. The human immunodeficiency virus type 1 Tat protein potentiates zidovudine-induced cellular toxicity in transgenic mice.
Prakash O; Teng S; Ali M; Zhu X; Coleman R; Dabdoub RA; Chambers R; Aw TY; Flores SC; Joshi BH
Arch Biochem Biophys; 1997 Jul; 343(2):173-80. PubMed ID: 9224727
[TBL] [Abstract][Full Text] [Related]
13. Lifetime treatment of mice with azidothymidine (AZT) produces myelodysplasia.
Inoue T; Cronkite EP; Hirabayashi Y; Bullis JE; Mitsui H; Umemura T
Leukemia; 1997 Apr; 11 Suppl 3():123-7. PubMed ID: 9209318
[TBL] [Abstract][Full Text] [Related]
14. NTP technical report on toxicity studies of urethane in drinking water and urethane in 5% ethanol administered to F344/N rats and B6C3F1 mice.
Chan PC
Toxic Rep Ser; 1996 Mar; (52):1-91, A1-9, B1-9 passim. PubMed ID: 11803705
[TBL] [Abstract][Full Text] [Related]
15. Cellular pharmacology of 3'-azido-3'-deoxythymidine with evidence of incorporation into DNA of human bone marrow cells.
Sommadossi JP; Carlisle R; Zhou Z
Mol Pharmacol; 1989 Jul; 36(1):9-14. PubMed ID: 2747633
[TBL] [Abstract][Full Text] [Related]
16. Effects of in vivo administration of stem cell factor on thrombopoiesis in normal and immunodeficient mice.
Chow FP; Zsebo K; Hamburger AW
Exp Hematol; 1993 Aug; 21(9):1255-62. PubMed ID: 7687220
[TBL] [Abstract][Full Text] [Related]
17. The effect of recombinant human granulocyte-macrophage colony-stimulating factor (rGM-CSF) on 3'-azido-3'-deoxythymidine (AZT)-mediated biochemical and cytotoxic effects on normal human myeloid progenitor cells.
Bhalla K; Birkhofer M; Grant S; Graham G
Exp Hematol; 1989 Jan; 17(1):17-20. PubMed ID: 2783247
[TBL] [Abstract][Full Text] [Related]
18. Prevention of hematopoietic myeloid and megakaryocyte toxicity associated with zidovudine in vivo in mice with recombinant GM-CSF.
Gallicchio VS; Hughes NK; Tse KF
Growth Regul; 1994 Jun; 4(2):41-7. PubMed ID: 7950902
[TBL] [Abstract][Full Text] [Related]
19. Immunologically mediated aplastic anemia in mice: evidence of hematopoietic stromal injury and injury to hematopoietic stem cells.
Knospe WH; Husseini SG; Chiu KM; Fried W
Exp Hematol; 1994 Jul; 22(7):573-81. PubMed ID: 8013573
[TBL] [Abstract][Full Text] [Related]
20. NTP technical report on the toxicity studies of Ethylene Glycol Ethers: 2-Methoxyethanol, 2-Ethoxyethanol, 2-Butoxyethanol (CAS Nos. 109-86-4, 110-80-5, 111-76-2) Administered in Drinking Water to F344/N Rats and B6C3F1 Mice.
Dieter M
Toxic Rep Ser; 1993 Jul; 26():1-G15. PubMed ID: 12209180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
